BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25759982)

  • 1. Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
    Shibayama Y; Kondo T; Ohya H; Fujisawa S; Teshima T; Iseki K
    Oncol Rep; 2015 May; 33(5):2176-82. PubMed ID: 25759982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
    Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
    PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.
    Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
    Biomark Med; 2015; 9(5):453-60. PubMed ID: 25620533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
    Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
    Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.
    Singh N; Heggermont W; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
    J Heart Lung Transplant; 2015 Nov; 34(11):1376-84. PubMed ID: 26198441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
    Zhang S; Zhang Q; Shi G; Yin J
    Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
    Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of miR-126 and miR-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients.
    Qiang L; Hong L; Ningfu W; Huaihong C; Jing W
    Int J Cardiol; 2013 Oct; 168(3):2082-8. PubMed ID: 23465244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
    Qian J; Lin J; Qian W; Ma JC; Qian SX; Li Y; Yang J; Li JY; Wang CZ; Chai HY; Chen XX; Deng ZQ
    Leuk Res; 2013 Jul; 37(7):765-8. PubMed ID: 23582927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.
    Ma QL; Wang JH; Yang M; Wang HP; Jin J
    J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
    Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
    Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study.
    Zhang X; Shao S; Geng H; Yu Y; Wang C; Liu Z; Yu C; Jiang X; Deng Y; Gao L; Zhao J
    J Clin Endocrinol Metab; 2014 May; 99(5):E766-74. PubMed ID: 24517143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW; Wen XM; Zhang YY; Yang L; Guo H; Yang J; Zhang M; Yin JY; Ma JC; Lin J; Deng ZQ; Qian J
    Int J Clin Exp Pathol; 2015; 8(5):4321-31. PubMed ID: 26191124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.